CTSO
Price:
$0.8705
Market Cap:
$47.38M
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and...[Read more]
Industry
Medical - Devices
IPO Date
2006-08-08
Stock Exchange
NASDAQ
Ticker
CTSO
According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 65.69M. This represents a change of -1.19% compared to the average of 66.48M of the last 4 quarters.
The mean historical Enterprise Value of Cytosorbents Corporation over the last ten years is 144.68M. The current 65.69M Enterprise Value has changed 4.44% with respect to the historical average. Over the past ten years (40 quarters), CTSO's Enterprise Value was at its highest in in the September 2018 quarter at 380.71M. The Enterprise Value was at its lowest in in the September 2022 quarter at 50.10M.
Average
144.68M
Median
138.89M
Minimum
53.75M
Maximum
238.99M
Discovering the peaks and valleys of Cytosorbents Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 381.65%
Maximum Annual Enterprise Value = 238.99M
Minimum Annual Increase = -55.60%
Minimum Annual Enterprise Value = 53.75M
Year | Enterprise Value | Change |
---|---|---|
2023 | 53.75M | -15.55% |
2022 | 63.64M | -55.60% |
2021 | 143.36M | -40.02% |
2020 | 238.99M | 86.61% |
2019 | 128.07M | -45.68% |
2018 | 235.78M | 36.96% |
2017 | 172.16M | 24.50% |
2016 | 138.28M | 3.74% |
2015 | 133.30M | -4.45% |
2014 | 139.50M | 381.65% |
The current Enterprise Value of Cytosorbents Corporation (CTSO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
86.92M
5-year avg
125.56M
10-year avg
144.68M
Cytosorbents Corporation’s Enterprise Value is greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (2.99B), less than Electromed, Inc. (175.39M), less than OrthoPediatrics Corp. (678.64M), less than Surmodics, Inc. (545.16M), less than NeuroPace, Inc. (246.80M), less than ClearPoint Neuro, Inc. (332.52M), less than TELA Bio, Inc. (119.53M), less than CVRx, Inc. (277.88M), less than Orthofix Medical Inc. (789.04M), less than Artivion, Inc. (1.46B), less than Heska Corporation (1.29B), less than Paragon 28, Inc. (570.08M), less than Inogen, Inc. (134.14M), less than Pulmonx Corporation (271.26M), greater than Apyx Medical Corporation (46.21M),
Company | Enterprise Value | Market cap |
---|---|---|
40.81M | $8.18M | |
2.99B | $2.66B | |
175.39M | $191.38M | |
678.64M | $695.92M | |
545.16M | $536.01M | |
246.80M | $185.98M | |
332.52M | $351.57M | |
119.53M | $104.63M | |
277.88M | $327.87M | |
789.04M | $661.57M | |
1.46B | $1.15B | |
1.29B | $1.31B | |
570.08M | $506.27M | |
134.14M | $214.18M | |
271.26M | $278.77M | |
46.21M | $40.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cytosorbents Corporation's Enterprise Value?
What is the highest Enterprise Value for Cytosorbents Corporation (CTSO)?
What is the 3-year average Enterprise Value for Cytosorbents Corporation (CTSO)?
What is the 5-year average Enterprise Value for Cytosorbents Corporation (CTSO)?
How does the current Enterprise Value for Cytosorbents Corporation (CTSO) compare to its historical average?